Coronary Artery Perforation During Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis

Canadian Journal of Cardiology

Volumn 27, Issue 6, 2011, Pages 843-850

  Shimony, Avi ^a   Joseph, Lawrence ^b   Mottillo, Salvatore ^a,c   Eisenberg, Mark J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CORONARY ARTERY PERFORATION; DISEASE CLASSIFICATION; DISEASE REGISTRY; EXCIMER LASER; HEART TAMPONADE; HUMAN; INCIDENCE; LASER ANGIOPLASTY; MEDICAL LITERATURE; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERICARDIOCENTESIS; REVIEW; STENT; SYSTEMATIC REVIEW;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY VESSELS; HUMANS; INTRAOPERATIVE COMPLICATIONS; MYOCARDIAL ISCHEMIA; RISK FACTORS; RUPTURE;

EID: 82155167631     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.04.014     Document Type: Review

References (40)

1. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21-e181.
2. Kiernan T.J., Yan B.P., Ruggiero N., et al. Coronary artery perforations in the contemporary interventional era. J Interv Cardiol 2009, 22:350-353.
3. Doll J.A., Nikolsky E., Stone G.W., et al. Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials. J Interv Cardiol 2009, 22:453-459.
4. Georgiadou P., Karavolias G., Sbarouni E., Adamopoulos S., Malakos J., Voudris V. Coronary artery perforation in patients undergoing percutaneous coronary intervention: a single-centre report. Acute Card Care 2009, 11:216-221.
5. Shimony A., Zahger D., Van Straten M., et al. Incidence, risk factors, management and outcomes of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol 2009, 104:1674-1677.
6. Shirakabe A., Takano H., Nakamura S., et al. Coronary perforation during percutaneous coronary intervention. Int Heart J 2007, 48:1-9.
7. Javaid A., Buch A.N., Satler L.F., et al. Management and outcomes of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol 2006, 98:911-914.
8. Ramana R.K., Arab D., Joyal D., et al. Coronary artery perforation during percutaneous coronary intervention: incidence and outcomes in the new interventional era. J Invasive Cardiol 2005, 17:603-605.
9. Stankovic G., Orlic D., Corvaja N., et al. Incidence, predictors, in-hospital, and late outcomes of coronary artery perforations. Am J Cardiol 2004, 93:213-216.
10. Witzke C.F., Martin-Herrero F., Clarke S.C., Pomerantzev E., Palacios I.F. The changing pattern of coronary perforation during percutaneous coronary intervention in the new device era. J Invasive Cardiol 2004, 16:257-301.
11. Fasseas P., Orford J.L., Panetta C.J., et al. Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16,298 procedures. Am Heart J 2004, 147:140-145.
12. Eggebrecht H., Ritzel A., von Birgelen C., et al. Acute and long-term outcome after coronary artery perforation during percutaneous coronary interventions. Z Kardiol 2004, 93:791-798.
13. Gunning M.G., Williams I.L., Jewitt D.E., Shah A.M., Wainwright R.J., Thomas M.R. Coronary artery perforation during percutaneous intervention: incidence and outcome. Heart 2002, 88:495-498.
14. Dippel E.J., Kereiakes D.J., Tramuta D.A., et al. Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management. Catheter Cardiovasc Interv 2001, 52:279-286.
15. Gruberg L., Pinnow E., Flood R., et al. Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol 2000, 86:680-682. A8.
16. Ellis S.G., Ajluni S., Arnold A.Z., et al. Increased coronary perforation in the new device era: incidence, classification, management, and outcome. Circulation 1994, 90:2725-2730.
17. Ajluni S.C., Glazier S., Blankenship L., O'Neill W.W., Safian R.D. Perforations after percutaneous coronary interventions: clinical, angiographic, and therapeutic observations. Cathet Cardiovasc Diagn 1994, 32:206-212.
18. Fukutomi T., Suzuki T., Popma J.J., et al. Early and late clinical outcomes following coronary perforation in patients undergoing percutaneous coronary intervention. Circ J 2002, 66:349-356.
19. Kini A.S., Rafael O.C., Sarkar K., et al. Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use. Catheter Cardiovasc Interv 2009, 74:700-707.
20. Bittl J.A., Ryan T.J., Keaney J.F., et al. Coronary artery perforation during excimer laser coronary angioplasty: the percutaneous Excimer Laser Coronary Angioplasty Registry. J Am Coll Cardiol 1993, 21:1158-1165.
21. Holmes D.R., Reeder G.S., Ghazzal Z.M., et al. Coronary perforation after excimer laser coronary angioplasty: the Excimer Laser Coronary Angioplasty Registry experience. J Am Coll Cardiol 1994, 23:330-335.
22. Morino Y., Kimura T., Hayashi Y., et al. In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion: insights from the J-CTO Registry (Multicenter CTO Registry in Japan). JACC Cardiovasc Interv 2010, 3:143-151.
23. Corcos T., Favereau X., Guérin Y., et al. Recanalization of chronic coronary occlusions using a new hydrophilic guidewire. Cathet Cardiovasc Diagn 1998, 44:83-90.
24. Levy J.H., Adkinson N.F. Anaphylaxis during cardiac surgery: implications for clinicians. Anesth Analg 2008, 106:392-403.
25. Horrow J.C. Protamine: a review of its toxicity. Anesth Analg 1985, 64:348-361.
26. Evora P.R.B., Pearson P.J., Schaff H.V. Protamine induces endothelium-dependent vasodilatation of the pulmonary artery. Ann Thorac Surg 1995, 60:405-410.
27. Click R.L., Hamburger H.A., Bove A.A. Complement activation from protamine sulfate after coronary angiography. Cathet Cardiovasc Diagn 1989, 16:221-225.
28. Briguori C., Di Mario C., De Gregorio J., Sheiban I., Vaghetti M., Colombo A. Administration of protamine after coronary stent deployment. Am Heart J 1999, 138:64-68.
29. Kaneda H., Suzuki J., Hosokawa G., Tanaka S., Hiroe Y., Saito S. Impact of heparin neutralization by protamine on restenosis after coronary stent implantation. Int J Cardiol 2005, 105:111-112.
30. Jamashidi P., Mahmoody K., Erne P. Covered stents: a review. Int J Cardiol 2008, 130:310-318.
31. Lansky A.J., Yang Y.M., Khan Y., et al. Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft. Am J Cardiol 2006, 98:370-374.
32. Ly H., Awaida J.P., Lespérance J., Bilodeau L. Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations. Am J Cardiol 2005, 95:244-246.
33. Briguori C., Nishida T., Anzuini A., Di Mario C., Grube E., Colombo A. Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures. Circulation 2000, 102:3028-3031.
34. Ben-Gal Y., Weisz G., Collins M.B., et al. Dual catheter technique for the treatment of severe coronary artery perforations. Catheter Cardiovasc Interv 2010, 75:708-712.
35. Fejka M., Dixon S.R., Safian R.D., et al. Diagnosis, management, and clinical outcome of cardiac tamponade complicating percutaneous coronary intervention. Am J Cardiol 2002, 90:1183-1186.
36. Oda H., Oda M., Makiyama Y., et al. Guidewire-induced coronary artery perforation treated with transcatheter delivery of subcutaneous tissue. Catheter Cardiovasc Interv 2005, 66:369-374.
37. Fischell T.A., Korban E.H., Lauer M.A. Successful treatment of distal coronary guidewire-induced perforation with balloon catheter delivery of intracoronary thrombin. Catheter Cardiovasc Interv 2003, 58:370-374.
38. Yoo B.S., Yoon J., Lee S.H., et al. Guidewire-induced coronary artery perforation treated with transcatheter injection of polyvinyl alcohol form. Catheter Cardiovasc Interv 2001, 52:231-234.
39. Aleong G., Jimenez-Quevedo P., Alfonso F. Collagen embolization for the successful treatment of a distal coronary artery perforation. Catheter Cardiovasc Interv 2009, 73:332-335.
40. Shah P.B. Management of coronary chronic total occlusion. Circulation 2011, 123:1780-1784.